NanoViricides Historical Cash Flow
| NNVC Stock | USD 1.68 0.04 2.44% |
Analysis of NanoViricides cash flow over time is an excellent tool to project NanoViricides future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 481 or Total Cash From Financing Activities of 5 M as it is a great indicator of NanoViricides ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining NanoViricides latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NanoViricides is a good buy for the upcoming year.
NanoViricides | Build AI portfolio with NanoViricides Stock |
About NanoViricides Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in NanoViricides balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which NanoViricides's non-liquid assets can be easily converted into cash.
NanoViricides Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from NanoViricides' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into NanoViricides current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.At present, NanoViricides' Total Cash From Financing Activities is projected to decrease significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 13.7 M, whereas Capital Expenditures is forecasted to decline to about 171 K.
NanoViricides cash flow statement Correlations
Click cells to compare fundamentals
NanoViricides Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NanoViricides cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Working Capital | (540.1K) | 214.6K | 1.8M | 996.9K | 1.1M | 1.2M | |
| Capital Expenditures | 238.8K | 324.3K | 151.7K | 156.6K | 180.0K | 171.0K | |
| Net Income | (8.8M) | (8.1M) | (8.6M) | (8.3M) | (7.5M) | (7.8M) | |
| Change In Cash | 6.8M | (6.5M) | (5.9M) | (3.4M) | (3.0M) | (2.9M) | |
| Free Cash Flow | (8.5M) | (6.2M) | (5.8M) | (6.5M) | (5.8M) | (6.1M) | |
| Total Cashflows From Investing Activities | (238.8K) | (324.3K) | (151.7K) | (156.6K) | (180.0K) | (189.0K) | |
| Other Cashflows From Financing Activities | (238.8K) | (324.3K) | (151.7K) | (156.6K) | (140.9K) | (133.9K) | |
| Depreciation | 704.5K | 723.3K | 747.5K | 759.0K | 872.9K | 463.8K | |
| Other Non Cash Items | 30.2K | 939.3K | 257.1K | 563.0 | 506.7 | 481.36 | |
| Total Cash From Operating Activities | (8.2M) | (5.9M) | (5.7M) | (6.3M) | (5.7M) | (6.0M) | |
| Total Cash From Financing Activities | 15.3M | (234.7K) | (94.8K) | 3.1M | 2.8M | 5.0M | |
| End Period Cash Flow | 20.5M | 14.1M | 8.1M | 4.8M | 5.5M | 5.2M | |
| Stock Based Compensation | 405.6K | 338.4K | 214.2K | 222.2K | 200.0K | 190.0K | |
| Begin Period Cash Flow | 13.7M | 20.5M | 14.1M | 8.1M | 9.4M | 13.7M | |
| Change To Netincome | 335.9K | 413.7K | 1.3M | 372.2K | 428.0K | 528.6K | |
| Change To Liabilities | 111K | (710.8K) | 40.8K | 118.1K | 106.3K | 111.6K | |
| Investments | (238.8K) | (324.3K) | (151.7K) | (156.6K) | (180.0K) | (189.0K) | |
| Net Borrowings | 1.1M | (1.3M) | (234.7K) | (94.8K) | (85.3K) | (81.0K) | |
| Change To Operating Activities | 9.0K | 170.6K | 173.8K | 1.7M | 1.9M | 2.0M | |
| Issuance Of Capital Stock | 16.6M | 6.1M | 0.0 | 3.1M | 2.8M | 2.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.